Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias

Overview of attention for article published in Clinical Epigenetics, May 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

TARGETING DOT1L AND SMARCA4/2 FOR THE TREATMENT OF MLLR LEUKEMIA

Application WO-2023004283-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.